Source author record

Jinyu Chen

Jinyu Chen appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

3works
5topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2026arXiv

HALO: Semantic-Aware Distributed LLM Inference in Lossy Edge Network

The deployment of large language models' (LLMs) inference at the edge can facilitate prompt service responsiveness while protecting user privacy. However, it is critically challenged by the resource constraints of a single edge node. Distributed inference has emerged to aggregate and leverage computational resources across multiple devices. Yet, existing methods typically require strict synchronization, which is often infeasible due to the unreliable network conditions. In this paper, we propose HALO, a novel framework that can boost the distributed LLM inference in lossy edge network. The core idea is to enable a relaxed yet effective synchronization by strategically allocating less critical neuron groups to unstable devices, thus avoiding the excessive waiting time incurred by delayed packets. HALO introduces three key mechanisms: (1) a semantic-aware predictor to assess the significance of neuron groups prior to activation. (2) a parallel execution scheme of neuron group loading during the model inference. (3) a load-balancing scheduler that efficiently orchestrates multiple devices with heterogeneous resources. Experimental results from a Raspberry Pi cluster demonstrate that HALO achieves a 3.41x end-to-end speedup for LLaMA-series LLMs under unreliable network conditions. It maintains performance comparable to optimal conditions and significantly outperforms the state-of-the-art in various scenarios.

preprint2022arXiv

Reinforced Structured State-Evolution for Vision-Language Navigation

Vision-and-language Navigation (VLN) task requires an embodied agent to navigate to a remote location following a natural language instruction. Previous methods usually adopt a sequence model (e.g., Transformer and LSTM) as the navigator. In such a paradigm, the sequence model predicts action at each step through a maintained navigation state, which is generally represented as a one-dimensional vector. However, the crucial navigation clues (i.e., object-level environment layout) for embodied navigation task is discarded since the maintained vector is essentially unstructured. In this paper, we propose a novel Structured state-Evolution (SEvol) model to effectively maintain the environment layout clues for VLN. Specifically, we utilise the graph-based feature to represent the navigation state instead of the vector-based state. Accordingly, we devise a Reinforced Layout clues Miner (RLM) to mine and detect the most crucial layout graph for long-term navigation via a customised reinforcement learning strategy. Moreover, the Structured Evolving Module (SEM) is proposed to maintain the structured graph-based state during navigation, where the state is gradually evolved to learn the object-level spatial-temporal relationship. The experiments on the R2R and R4R datasets show that the proposed SEvol model improves VLN models' performance by large margins, e.g., +3% absolute SPL accuracy for NvEM and +8% for EnvDrop on the R2R test set.

preprint2020arXiv

Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients

We aimed to develop a population pharmacokinetic model of tacrolimus in Chinese lung transplant recipients, and propose model based dosing regimens for individualized treatment. We obtained 807 tacrolimus whole blood concentrations from 52 lung transplant patients and genotyped CYP3A5*3. Population pharmacokinetic analysis was performed using nonlinear mixed effects modeling. Monte Carlo simulations were employed to design initial dosing regimens. Tacrolimus pharmacokinetics was described by a one compartment model with first order absorption and elimination process. The mean estimated apparent clearance was 13.1 l/h with 20.1% inter subject variability in CYP3A5*3/*3 70kg patients with 30% hematocrit and voriconazole free therapy, which is lower than that in Caucasian(17.5 to 36.5 l/h). Hematocrit, postoperative days, tacrolimus daily dose, voriconazole cotherapy, and CYP3A5*3 genotype were identified as significant covariates for tacrolimus clearance. To achieve the target trough concentration (10 to 15 ng/ml) on the 8th day after transplantation, CYP3A5*1/*3 patients with voriconazole free cotherapy, a higher initial dosage than the current regimen of 0.04 mg/kg q12h should be recommened. Given the nonlinear kinetics of tacrolimus and large variability, population pharmacokinetic model should be combined with therapeutic drug monitoring to optimize individualized therapy.